Rock Springs Capital Management as of Dec. 31, 2015
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 119 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Allergan | 3.8 | $51M | 162k | 312.50 | |
Aetna | 3.4 | $44M | 411k | 108.12 | |
Acadia Healthcare (ACHC) | 3.2 | $42M | 675k | 62.46 | |
Alexion Pharmaceuticals | 2.8 | $37M | 193k | 190.75 | |
Radius Health | 2.8 | $37M | 598k | 61.54 | |
Gilead Sciences (GILD) | 2.5 | $33M | 325k | 101.19 | |
Baxalta Incorporated | 2.4 | $32M | 810k | 39.03 | |
Pfizer (PFE) | 2.4 | $32M | 975k | 32.28 | |
Hca Holdings (HCA) | 2.2 | $29M | 430k | 67.63 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.1 | $28M | 1.0M | 27.50 | |
Celgene Corporation | 2.1 | $28M | 230k | 119.76 | |
Spark Therapeutics | 1.9 | $25M | 560k | 45.31 | |
Advanced Accelerat spon ads each rep 2 ord | 1.9 | $25M | 800k | 31.27 | |
Teva Pharmaceutical Industries (TEVA) | 1.9 | $25M | 379k | 65.64 | |
Aclaris Therapeutics (ACRS) | 1.8 | $24M | 896k | 26.94 | |
Medicines Company | 1.8 | $23M | 625k | 37.34 | |
Eli Lilly & Co. (LLY) | 1.8 | $23M | 276k | 84.26 | |
Intuitive Surgical (ISRG) | 1.6 | $22M | 40k | 546.15 | |
Neurocrine Biosciences (NBIX) | 1.6 | $21M | 378k | 56.57 | |
Pacira Pharmaceuticals (PCRX) | 1.5 | $20M | 260k | 76.79 | |
CIGNA Corporation | 1.4 | $18M | 122k | 146.33 | |
Tesaro | 1.3 | $18M | 334k | 52.32 | |
Prothena (PRTA) | 1.3 | $17M | 248k | 68.11 | |
Anthem (ELV) | 1.3 | $17M | 121k | 139.44 | |
WellCare Health Plans | 1.3 | $17M | 215k | 78.21 | |
Biogen Idec (BIIB) | 1.2 | $16M | 51k | 306.36 | |
McKesson Corporation (MCK) | 1.1 | $14M | 73k | 197.23 | |
Thermo Fisher Scientific (TMO) | 1.1 | $14M | 100k | 141.85 | |
Mednax (MD) | 1.1 | $14M | 193k | 71.66 | |
Incyte Corporation (INCY) | 1.0 | $14M | 127k | 108.45 | |
Amgen (AMGN) | 1.0 | $13M | 81k | 162.32 | |
Galapagos Nv- (GLPG) | 1.0 | $13M | 210k | 62.88 | |
Retrophin | 1.0 | $13M | 675k | 19.29 | |
Ardelyx (ARDX) | 0.9 | $12M | 683k | 18.12 | |
Therapeuticsmd | 0.9 | $12M | 1.2M | 10.37 | |
Achillion Pharmaceuticals | 0.9 | $12M | 1.1M | 10.79 | |
Ultragenyx Pharmaceutical (RARE) | 0.9 | $12M | 106k | 112.18 | |
Aduro Biotech | 0.9 | $12M | 415k | 28.14 | |
Pra Health Sciences | 0.9 | $12M | 253k | 45.27 | |
Jazz Pharmaceuticals (JAZZ) | 0.9 | $11M | 80k | 140.56 | |
Penumbra (PEN) | 0.8 | $11M | 205k | 53.81 | |
Wright Medical Group Nv | 0.8 | $11M | 456k | 24.18 | |
Theravance Biopharma (TBPH) | 0.8 | $11M | 645k | 16.39 | |
Dermira | 0.8 | $10M | 290k | 34.61 | |
Cardiome Pharma | 0.7 | $9.7M | 1.2M | 8.11 | |
Insys Therapeutics | 0.7 | $9.7M | 339k | 28.63 | |
Intra Cellular Therapies (ITCI) | 0.7 | $9.7M | 180k | 53.79 | |
Chiasma | 0.7 | $9.5M | 488k | 19.57 | |
IDEXX Laboratories (IDXX) | 0.7 | $9.3M | 128k | 72.92 | |
Adaptimmune Therapeutics (ADAP) | 0.7 | $9.2M | 765k | 12.06 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.7 | $9.2M | 73k | 125.83 | |
Anacor Pharmaceuticals In | 0.7 | $8.7M | 77k | 112.97 | |
Juno Therapeutics | 0.7 | $8.7M | 197k | 43.97 | |
Seres Therapeutics (MCRB) | 0.7 | $8.6M | 245k | 35.09 | |
Valeant Pharmaceuticals Int | 0.6 | $8.5M | 84k | 101.65 | |
Portola Pharmaceuticals | 0.6 | $8.5M | 165k | 51.45 | |
HeartWare International | 0.6 | $8.1M | 161k | 50.40 | |
Gw Pharmaceuticals Plc ads | 0.6 | $8.1M | 116k | 69.44 | |
Inovalon Holdings Inc Cl A | 0.6 | $8.1M | 477k | 17.00 | |
Insmed (INSM) | 0.6 | $7.8M | 433k | 18.15 | |
Intersect Ent | 0.6 | $7.6M | 337k | 22.50 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $7.3M | 70k | 104.76 | |
RTI Biologics | 0.6 | $7.4M | 1.9M | 3.97 | |
Relypsa | 0.5 | $7.1M | 252k | 28.34 | |
Novadaq Technologies | 0.5 | $6.9M | 540k | 12.74 | |
Healthsouth | 0.5 | $6.8M | 195k | 34.81 | |
Macrogenics (MGNX) | 0.5 | $6.8M | 218k | 30.97 | |
Tandem Diabetes Care | 0.5 | $6.6M | 563k | 11.81 | |
Novavax | 0.5 | $6.5M | 770k | 8.39 | |
Coherus Biosciences (CHRS) | 0.5 | $6.5M | 282k | 22.96 | |
athenahealth | 0.5 | $6.4M | 40k | 160.96 | |
Envision Healthcare Hlds | 0.5 | $6.4M | 245k | 25.97 | |
Sarepta Therapeutics (SRPT) | 0.5 | $6.2M | 161k | 38.58 | |
XenoPort | 0.5 | $6.0M | 1.1M | 5.49 | |
Regeneron Pharmaceuticals (REGN) | 0.5 | $6.0M | 11k | 542.91 | |
Cooper Companies | 0.5 | $5.9M | 44k | 134.20 | |
Epizyme | 0.5 | $5.9M | 370k | 16.02 | |
Fibrogen (FGEN) | 0.4 | $5.8M | 190k | 30.47 | |
Amicus Therapeutics (FOLD) | 0.4 | $5.5M | 567k | 9.70 | |
CHINA CORD Blood Corp | 0.4 | $5.6M | 880k | 6.37 | |
Five Prime Therapeutics | 0.4 | $5.6M | 135k | 41.50 | |
Otonomy | 0.4 | $5.5M | 198k | 27.75 | |
Compugen (CGEN) | 0.4 | $5.1M | 805k | 6.39 | |
Abbvie (ABBV) | 0.4 | $5.2M | 88k | 59.25 | |
Invitae (NVTAQ) | 0.4 | $5.1M | 623k | 8.21 | |
Allergan Plc pfd conv ser a | 0.4 | $5.1M | 5.0k | 1027.20 | |
Kite Pharma | 0.4 | $4.9M | 80k | 61.62 | |
Ascendis Pharma A S (ASND) | 0.4 | $4.9M | 270k | 18.32 | |
Endochoice Hldgs | 0.4 | $4.9M | 590k | 8.35 | |
Aimmune Therapeutics | 0.4 | $4.8M | 260k | 18.45 | |
Novocure Ltd ord (NVCR) | 0.4 | $4.8M | 214k | 22.36 | |
Dyax | 0.3 | $4.7M | 124k | 37.62 | |
Clovis Oncology | 0.3 | $4.4M | 125k | 35.00 | |
Perrigo Company (PRGO) | 0.3 | $4.3M | 30k | 144.70 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $4.3M | 250k | 17.16 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.3 | $4.1M | 415k | 9.83 | |
Scynexis | 0.3 | $3.9M | 635k | 6.21 | |
Nivalis Therapeutics | 0.3 | $3.8M | 489k | 7.74 | |
Dynavax Technologies (DVAX) | 0.3 | $3.6M | 150k | 24.16 | |
Rigel Pharmaceuticals | 0.2 | $3.3M | 1.1M | 3.03 | |
Egalet | 0.2 | $3.3M | 300k | 11.02 | |
Dimension Therapeutics | 0.2 | $3.1M | 271k | 11.28 | |
Orexigen Therapeutics | 0.2 | $2.8M | 1.7M | 1.72 | |
Assembly Biosciences | 0.2 | $2.8M | 371k | 7.51 | |
Genocea Biosciences | 0.2 | $2.5M | 480k | 5.27 | |
Intercept Pharmaceuticals In | 0.2 | $2.3M | 16k | 149.35 | |
Global Blood Therapeutics In | 0.2 | $2.3M | 71k | 32.33 | |
Nabriva Therapeutics | 0.2 | $2.2M | 235k | 9.55 | |
Tetraphase Pharmaceuticals | 0.1 | $2.0M | 200k | 10.03 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $1.7M | 215k | 7.85 | |
Anthera Pharmaceutcls | 0.1 | $1.8M | 380k | 4.64 | |
Cerulean Pharma | 0.1 | $1.8M | 625k | 2.80 | |
Bluebird Bio (BLUE) | 0.1 | $1.3M | 20k | 64.20 | |
Sophiris Bio | 0.1 | $1.1M | 629k | 1.81 | |
Puma Biotechnology (PBYI) | 0.1 | $862k | 11k | 78.36 | |
Dbv Technologies S A | 0.1 | $908k | 25k | 36.32 | |
Mirna Therapeutics | 0.1 | $938k | 150k | 6.25 | |
Paratek Pharmaceuticals | 0.0 | $585k | 31k | 18.98 | |
Aratana Therapeutics | 0.0 | $242k | 43k | 5.57 |